The Human Story Behind the Science
She Traveled Far.
Too Far.
When Kara Weatherman was diagnosed with cancer, she became more than a patient. She became a witness. She experienced firsthand what radiopharmaceutical treatment in America looks like today: fragmented, exhausting, and profoundly disconnected from the human being at the center of it.
She drove hours for treatment. She managed logistics no sick person should manage. She received medicine developed by researchers who never saw her face, delivered by technicians who never knew her name, in facilities with no place for her family to rest.
Today, Dr. Kara D. Weatherman, PharmD, BCNP, FAPhA, serves as Clinical Professor of Pharmacy Practice and Director of Radiopharmaceutical Programs at Purdue University, where she leads the university's nuclear pharmacy program. She is building the workforce for tomorrow's most important class of cancer treatments. And when she heard the vision for this campus, she did not hesitate: she has been waiting for someone to build it.
"What's missing is the whole patient. We treat the cancer with extraordinary science. We can do so much more for the person."
Dr. Kara D. Weatherman
Director, Radiopharmaceutical Programs · Purdue University
What the System Gets Wrong
Five Gaps That
This Campus Closes
-
01
Fragmented Care Journey
Patients travel to separate facilities for diagnosis, imaging, infusion, and dosimetry follow-up. No single destination coordinates their entire treatment arc.
-
02
Researcher-Patient Disconnect
Scientists developing life-saving isotopes rarely encounter the people who receive them. Purpose and mission become abstracted from human outcome.
-
03
No Place for Caregivers
Family members who travel with patients have nowhere dignified to wait, rest, or receive support. The caregiver is invisible to the system.
-
04
Supply Chain Vulnerability
Radiopharmaceuticals have half-lives measured in hours, not days. Treatment depends on a fragile, time-critical supply chain with no redundancy.
-
05
Workforce Pipeline Shortage
The radiopharma revolution is arriving faster than the talent to deliver it. Nuclear pharmacists, dosimetrists, and clinical trial coordinators are already scarce.
